Public shareholder Smallcap World Fund, Inc., a Capital Group arm, offloaded stock worth Rs 756 crore in Neuland Laboratories ...

AbbVie (NYSE: ABBV) recently dipped nearly 20% and is still down 14%, offering an enticing 3.7% forward yield. Here's what ...

We recently published a list of 10 Best Safe Stocks To Buy According to Analysts. In this article, we are going to take a ...

NextRNA Therapeutics, a biotechnology company focused on developing transformative medicines to address long non-coding RNA (lncRNA)-driven diseases, today announced the appointment of Charles (Chuck) ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Investing in blue chips at 52-week lows can potentially yield significant returns if fundamentals are strong. Find out 5 high ...

AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Aliada Therapeutics. With the completion of the ...

Europe active pharmaceutical ingredients (API) market was valued at $ 49.4 billion in 2022 and will grow by 6.8% annually over 2022-2032, driven by rising adoption of biologics in disease management, ...

Request To Download Sample of This Strategic Report@ Taiwan says China sending largest naval fleet in years to region Highlighted with 82 tables and 75 figures, this 197-page report ?North America ...

Shares of AbbVie Inc. ABBV slipped 0.74% to $174.37 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.82% to 6,084.19 and ...

AbbVie has completed its acquisition of Aliada Therapeutics which includes Aliada’s disease-modifying therapy for Alzheimer’s disease.